Novo Nordisk has asked the FDA to dam manufacture of compounded copies of copyright, arguing that it’s as well tough to do safely. It’s the latest escalation within a brewing war among pharmaceutical companies and compounders.“Individuals are obtaining it from friends or individuals on the road, with no understanding of where it arrived from